Indeed, the BBB’s breakdown has been suggested as an early marker for AD; yet, the relationship between the BBB’s breakdown and AD-specific biomarkers based on the amyloid/tau/neurodegeneration framework still needs more clarification [319]. Here, MAPT is linked to Alzheimer disease.